Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Ventyx Biosciences Inc’s stock clocked out at $8.8, up 0.92% from its previous closing price of $8.72. In other words, the price has increased by $0.92 from its previous closing price. On the day, 1.85 million shares were traded. VTYX stock price reached its highest trading level at $9.1293 during the session, while it also had its lowest trading level at $8.73.
Ratios:
To gain a deeper understanding of VTYX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.86 and its Current Ratio is at 17.86. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On March 12, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7 to $16.
Oppenheimer Upgraded its Perform to Outperform on March 12, 2024, while the target price for the stock was maintained at $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Nuss John sold 1,887 shares for $1.07 per share. The transaction valued at 2,019 led to the insider holds 467,226 shares of the business.
Nuss John sold 21,119 shares of VTYX for $49,841 on Dec 27 ’24. The CHIEF SCIENTIFIC OFFICER now owns 464,582 shares after completing the transaction at $2.36 per share. On Dec 27 ’24, another insider, Nuss John, who serves as the Officer of the company, bought 21,119 shares for $2.36 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 627956032 and an Enterprise Value of 439633312.
Stock Price History:
The Beta on a monthly basis for VTYX is 1.24, which has changed by 2.1366906 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, VTYX has reached a high of $10.55, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 27.13%, while the 200-Day Moving Average is calculated to be 172.41%.
Shares Statistics:
It appears that VTYX traded 4.24M shares on average per day over the past three months and 2045610 shares per day over the past ten days. A total of 71.34M shares are outstanding, with a floating share count of 64.07M. Insiders hold about 10.22% of the company’s shares, while institutions hold 62.14% stake in the company. Shares short for VTYX as of 1763078400 were 6151028 with a Short Ratio of 1.45, compared to 1760486400 on 1402079. Therefore, it implies a Short% of Shares Outstanding of 6151028 and a Short% of Float of 9.16.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate. The current performance of Ventyx Biosciences Inc (VTYX) in the stock market.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.35 and -$1.57 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.61, with 7.0 analysts recommending between -$1.14 and -$2.1.
